Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (1862)	1/22/2002 11:57:32 PM
From: Miljenko Zuanic	Respond to of 2515

Cacaito, <<Miljenko, infantile you keep asking for leak from FDA, again most probably leak came from someone else.>> Who is that someone else? Why not from FDA? <<The Cancer Letter only published AFTER the Wacksals talk 12/28/01, it was the BLATANT LIE from Imcl that made the big news, few would have care if it came before.>> What will IMCL report is in part controlled by MBY, after deal. <<You are infantile to keep looking for blame somewhere else.>> I am not looking at all for anyone to blame. Why should I? <<Another copy of the RTF end up in Baron’s hand, they are giving about the same from it.>> Barron's hand? One more reason to question truth of the letter content? <<Ask for a full copy to Imcl management.>> When I think twice, I do not need this RTF at all. My opinion on C225 (after last ASCO) did not change. <<You are tired of Imcl discusion, but obviously not tired of calling names and adjudicating behavior or teasing. >> I am tired of the facts discussions, when they are naive and transparent. I am not discussion IMCL at all. Miljenko